Long COVID remains globally prevalent following COVID-19 infection, with a significant burden of symptoms lasting 1 to 2 years postinfection.

Four Western states are taking a different approach from the CDC on vaccines for COVID-19, influenza, and RSV.

The respiratory syncytial virus (RSV) vaccine reduces RSV-associated hospitalization among older adults over 2 seasons.

Eric K. Singhi, MD, is a thoracic oncologist at MD Anderson Cancer Center in Houston and one of Cancer Therapy Advisor’s editorial board members. He shares his top 5 presentations from the 2025 World ...

Illinois health officials are warning residents to be on alert after the state’s first case of Powassan virus was confirmed in a resident who became seriously ill.

The FDA has approved updated prescribing information for Airsupra to include the BATURA study in patients with mild asthma.

The prevalence of ever, current, and daily use of nicotine pouches was low; a significantly higher prevalence was seen for adults who were male and non-Hispanic White. HealthDay News — The percentage ...

An abnormal spirometry phenotype has been found by age 8 in more than 25% of children born extremely preterm or extremely low birth weight.

Nocturnal gastro-esophageal reflux (nGER) has no significant link to pulmonary abnormalities in middle-aged adults.

Dual vs mono antiviral therapy demonstrated superior mortality reduction among high-risk, hospitalized patients with severe ...

A phase 3 trial evaluating benralizumab for the treatment of COPD did not meet its primary endpoint, according to AstraZeneca.

Topline data were announced from a phase 3 trial evaluating efzofitimod in patients with pulmonary sarcoidosis.